Capecitabine plus paclitaxel as first- Or second-line therapy: A multicenter phase II study in metastatic breast cancer

L. A. Meza, B. Amin, T. Hill, Y. M. Chen, S. A. Petralia, W. J. Gradishar

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'Capecitabine plus paclitaxel as first- Or second-line therapy: A multicenter phase II study in metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences